CNBC Africa

Newsfeed

NOVAVAX – DATA SHOWED COVID-19 VACCINE CANDIDATE DRAMATICALLY REDUCED MILD AND MODERATE DISEASE ACROSS UK, SOUTH AFRICA TRIALS

PUBLISHED: Thu, 11 Mar 2021 21:02:03 GMT

NOVAVAX – DATA SHOWED COVID-19 VACCINE CANDIDATE DRAMATICALLY REDUCED MILD AND MODERATE DISEASE ACROSS UK, SOUTH AFRICA TRIALS

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html